Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4798983
Max Phase: Preclinical
Molecular Formula: C57H71N15O8
Molecular Weight: 1094.29
Molecule Type: Unknown
Associated Items:
ID: ALA4798983
Max Phase: Preclinical
Molecular Formula: C57H71N15O8
Molecular Weight: 1094.29
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)CCc1cccnc1)C(=O)N[C@@H](CC(N)=O)C(N)=O
Standard InChI: InChI=1S/C57H71N15O8/c58-48(73)33-44(50(59)75)70-51(76)42(15-7-27-65-56(60)61)68-54(79)47-17-9-29-72(47)55(80)43(16-8-28-66-57(62)63)69-53(78)46(31-35-18-22-40(23-19-35)38-11-2-1-3-12-38)71-52(77)45(67-49(74)25-21-36-10-6-26-64-34-36)32-37-20-24-39-13-4-5-14-41(39)30-37/h1-6,10-14,18-20,22-24,26,30,34,42-47H,7-9,15-17,21,25,27-29,31-33H2,(H2,58,73)(H2,59,75)(H,67,74)(H,68,79)(H,69,78)(H,70,76)(H,71,77)(H4,60,61,65)(H4,62,63,66)/t42-,43-,44-,45-,46-,47-/m0/s1
Standard InChI Key: NHGFIVRJXHRKQA-FQEQRRFLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1094.29 | Molecular Weight (Monoisotopic): 1093.5610 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Takayama K,Mori K,Asari T,Sohma Y,Nomura E,Sasaki Y,Taguchi A,Taniguchi A,Miyazato M,Minamino N,Kangawa K,Hayashi Y. (2020) Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability., 30 (18): [PMID:32721452] [10.1016/j.bmcl.2020.127436] |
Source(1):